(Q50529471)
Statements
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q. (English)
1 reference
Pierre Fenaux
1 reference
Carlo Aul
1 reference
Aristoteles Giagounidis
1 reference
Uwe Platzbecker
1 reference
Petra Muus
1 reference
Robert Knight
1 reference
Dominik Selleslag
1 reference
Odile Beyne-Rauzy
1 reference
Ghulam Mufti
1 reference
Moshe Mittelman
1 reference
Peter Te Boekhorst
1 reference
Guillermo Sanz
1 reference
Consuelo Del Cañizo
1 reference
Agnes Guerci-Bresler
1 reference
Lars Nilsson
1 reference
Michael Lübbert
1 reference
Bruno Quesnel
1 reference
Mario Cazzola
1 reference
Arnold Ganser
1 reference
David Bowen
1 reference
Brigitte Schlegelberger
1 reference
John Francis
1 reference
Tommy Fu
1 reference
Eva Hellström-Lindberg
1 reference
MDS-004 Lenalidomide del5q Study Group
1 reference
13 July 2011
1 reference
1 reference
118
1 reference
14
1 reference
3765-3776
1 reference
Identifiers
1 reference